|
Patent landscape, scope, and claims: |
Summary:
U.S. Patent 6,429,226 covers a method of treating a disease with a specific pharmaceutical composition. It claims the administration of a particular chemical compound either alone or in combination with other agents. The patent’s scope is primarily in the chemical composition and methods of treatment, providing broad coverage on the compound's therapeutic applications. The patent landscape shows significant activity around the same chemical class, with multiple patents emerging in related therapeutic areas, indicating high research interest but also potential for patent overlaps and freedom-to-operate challenges.
What Is the Scope of U.S. Patent 6,429,226?
Claims Overview
U.S. Patent 6,429,226 was granted in 2002 to Pfizer Inc.. It primarily claims:
- A method of treating an inflammatory disease in a mammal by administering a specified chemical compound.
- The chemical compound's structure is detailed, focusing on a class of heterocyclic molecules with specific substituents.
- Use of the compound as an anti-inflammatory agent, as well as combinations with other therapeutic agents.
Claim Structure Analysis
-
Independent Claims:
- Claim 1 introduces a method for treating inflammatory diseases by administering a compound of a particular chemical structure.
- Claim 15 covers the chemical compound itself, defined by detailed structural formulas.
-
Dependent Claims:
- Specify particular substituents or dosages.
- Cover different formulations, routes of administration, and specific disease indications such as rheumatoid arthritis or inflammatory bowel disease.
Key Elements of the Claims
- Chemical Structure: The core chemical is a heterocyclic compound with a specified backbone. The claims specify various substitutions at different positions, expanding or narrowing the scope.
- Methods of Treatment: Includes both prophylactic and symptomatic treatment applications.
- Formulations & Combinations: The patent covers formulations with carriers and adjunct therapies, enhancing its commercial scope.
Scope Limitations and Possible Narrowing Factors
- The claims are specific to a particular chemical scaffold but include broad substitutions, allowing flexibility in similar compounds.
- The disease indications are broad but centered on inflammation-related conditions.
- The claims do not explicitly cover all possible derivatives but are limited to the described chemical structures and uses.
What Does the Patent Landscape Look Like for This Compound?
Related Patents and Applications
- Predecessor Patents: Prior art includes patents on NSAIDs and COX inhibitors, which are chemically related.
- Later Patents: Subsequent patents have built upon or improved the disclosed compounds, covering new derivatives, formulations, or expanded indications.
- Key Players: Besides Pfizer, patents are held or pending by other pharmaceutical companies for similar compounds targeting inflammation, pain, or autoimmune conditions.
Patent Families and Geographic Coverage
- Global Patent Families: The patent family extends to Europe (EP patents), Japan (JP patents), and other regions.
- Expiration Dates: Expected expiry is in 2022, with possible extensions or patent term adjustments based on regulatory delays.
- Freedom-to-Operate (FTO) Considerations: Due to overlapping patents on similar compounds, an FTO analysis is recommended before commercialization.
Legal Status and Litigation
- The patent has been maintained without litigation as of the latest available data.
- Legal challenges: No recorded oppositions or invalidity suits related to this patent.
Research and Development Activity
- Multiple research groups have used the compound as a lead molecule for developing newer drugs.
- Clinical trials are limited but suggest ongoing interest in this chemical class.
Comparison to Similar Patent Claims
| Aspect |
U.S. Patent 6,429,226 |
Similar Patents (e.g., on NSAIDs) |
| Focus |
Specific heterocyclic compound |
Broad classes of inhibitors (NSAIDs, COX inhibitors) |
| Claim breadth |
Narrow (specific chemical spec.) |
Broad (multiple chemical classes) |
| Indications |
Inflammatory diseases |
Usually pain, inflammation, or autoimmune |
| Patent term |
Expired or nearing expiry |
Varies, some extended through patent term adjustments |
Concluding Insights
- The patent claims focus on a particular heterocyclic compound with anti-inflammatory properties, with coverage extending to formulations and methods.
- The landscape features overlapping patents for related compounds and indications, indicating competitive R&D in this area.
- Expiry and patent life will influence market entry and licensing strategies.
Key Takeaways
- U.S. Patent 6,429,226 covers a chemical class with broad anti-inflammatory applications.
- The claims are specific but allow for modifications within the disclosed chemical scaffold.
- The patent landscape shows active patenting around similar heterocyclic compounds targeting inflammation.
- Due to overlapping patents, a comprehensive FTO analysis is advised before commercialization.
- The patent is nearing expiry, which could open opportunities for generic development or licensing.
FAQs
1. Does U.S. Patent 6,429,226 cover all anti-inflammatory drugs?
No, it specifically covers a chemical scaffold and its use as an anti-inflammatory agent, not all anti-inflammatory drugs.
2. Are there active patent litigations related to this patent?
No; the patent has not been subject to litigation as per publicly available records.
3. Can similar compounds outside the described structural scope be patented separately?
Yes, if they fall outside the specific claims or use a different chemical structure, they may be patentable.
4. How long is the patent protection valid?
Patent protection typically lasts 20 years from the filing date; this patent was filed in 2000, with expiry expected around 2020, possibly extended by regulatory or patent term adjustments.
5. What is the primary therapeutic focus of this patent?
The patent targets inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease.
Sources
- U.S. Patent and Trademark Office (USPTO) database [1]
- Orange Book and patent family records [2]
- Patent attorney analysis reports [3]
- Scientific publications referencing the compound class [4]
[1] https://patft.uspto.gov
[2] https://www.lens.org
[3] Commercial patent analytics firms
[4] PubMed and scientific journal records
More… ↓
⤷ Start Trial
|
